Bastards | Guest: Clayton Cobb | 2/17/22
Steve Deace Show
00:00
Let's Not Lose Control
In honor of rush, i would like to lose control. I know that you would. So then we're to begin with a preprint study done in real time by clinitians and doctors who are treating critical care with covet. What they show is the fourth jab in israel, the fizerva, only offers at best a 30 % efficacy against covate infection - which means 70% of the time. And it increases even higher for what they call personal or 'mio cardidus' side effects such as an elevated heart rate. It's on all my social media accounts right now. If you go look for it.
Play episode from 17:04
Transcript
